| 000 | 01384 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250512035817.0 | ||
| 264 | 0 | _c19890317 | |
| 008 | 198903s 0 0 eng d | ||
| 022 | _a1040-3787 | ||
| 024 | 7 |
_a10.1002/ajmg.1320310629 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSantavuori, P | |
| 245 | 0 | 0 |
_aExperience over 17 years with antioxidant treatment in Spielmeyer-Sjögren disease. _h[electronic resource] |
| 260 |
_bAmerican journal of medical genetics. Supplement _c1988 |
||
| 300 |
_a265-74 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntioxidants _xtherapeutic use |
| 650 | 0 | 4 |
_aAscorbic Acid _xtherapeutic use |
| 650 | 0 | 4 |
_aButylated Hydroxytoluene _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethionine _xtherapeutic use |
| 650 | 0 | 4 |
_aNeuronal Ceroid-Lipofuscinoses _xdrug therapy |
| 650 | 0 | 4 |
_aVitamin E _xtherapeutic use |
| 700 | 1 | _aHeiskala, H | |
| 700 | 1 | _aWestermarck, T | |
| 700 | 1 | _aSainio, K | |
| 700 | 1 | _aMoren, R | |
| 773 | 0 |
_tAmerican journal of medical genetics. Supplement _gvol. 5 _gp. 265-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ajmg.1320310629 _zAvailable from publisher's website |
| 999 |
_c3152121 _d3152121 |
||